Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
12:25pm, Friday, 08'th Jul 2022
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Here's Why You Should Hold on to Avanos (AVNS) Stock For Now
10:32am, Tuesday, 07'th Jun 2022
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2022 Results - Earnings Call Transcript
07:45am, Sunday, 08'th May 2022
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2022 Earnings Conference Call May 7, 2022 9:00 AM ET Company Participants Scott Galovan - Vice President, Corporate Strategy and Business Development Joe Woody - C
Avanos Medical (AVNS) Q1 Earnings, Revenues Top Estimates
12:02pm, Friday, 06'th May 2022
Avanos Medical's (AVNS) first-quarter 2022 results reflect strength in the Pain Management segment.
Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates
09:47am, Wednesday, 04'th May 2022
Avanos Medical (AVNS) delivered earnings and revenue surprises of 8.33% and 0.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Love Dirt-Cheap Growth Stocks? Check Out This Under-The-Radar Buy
08:30am, Sunday, 01'st May 2022
There's a reason why it's so cheap, but it isn't a deal breaker.
Is Avanos Medical (AVNS) Stock Outpacing Its Medical Peers This Year?
11:18am, Monday, 04'th Apr 2022
Here is how Avanos Medical (AVNS) and Axcella Health Inc. (AXLA) have performed compared to their sector so far this year.
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum
09:34am, Tuesday, 15'th Mar 2022
ALPHARETTA, Ga., March 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financ
New Strong Buy Stocks for March 11th
08:17am, Friday, 11'th Mar 2022
ABM, AVNS, ASIX, AA, and ESEA have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2022.
Avanos Medical's (AVNS) CEO Joe Woody on Q4 2021 Results - Earnings Call Transcript
01:33pm, Wednesday, 23'rd Feb 2022
Avanos Medical's (AVNS) CEO Joe Woody on Q4 2021 Results - Earnings Call Transcript
Recap: Avanos Medical Q4 Earnings
12:33pm, Wednesday, 23'rd Feb 2022 Benzinga
Avanos Medical (NYSE: AVNS ) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Avanos Medical beat estimated earnings by 15.0%, reporting an EPS of $0.46 versus Full story available on Benzinga.com
Avanos Medical Non-GAAP EPS of $0.46 beats by $0.06, revenue of $193.4M beats by $2.08M
12:08pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Avanos Medical press release (AVNS): Q4 Non-GAAP EPS of $0.46 beats by $0.06.Revenue of $193.4M (+4.5% Y/Y) beats by $2.08M.The company expects FY2022 net sales to be between $830M
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
10:00am, Wednesday, 23'rd Feb 2022
Avanos Medical (AVNS) delivered earnings and revenue surprises of 15% and 1.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical Q4 2021 Earnings Preview
04:24pm, Tuesday, 22'nd Feb 2022 Seeking Alpha
Avanos Medical (NYSE:AVNS) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, before market open.The consensus EPS Estimate is $0.40 (+42.9% Y/Y) and the
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
11:35am, Tuesday, 15'th Feb 2022
ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full
